FORTIS ANANDAPUR LAUNCHES STATE-OF-THE-ART ‘LUNG AND HEART CLINIC’
KOLKATA : Fortis Anandpur has launched a state-of-the-art Lung and Heart Clinic that aims to provide clinical excellence and quality care to patients with end-stage heart and lung ailments. The clinic will provide a multidisciplinary approach by providing holistic care and work in tandem with other clinical specialties to ensure that patients receive the best possible treatment – including diagnosis, treatment, and follow-up care for those requiring a heart or lung transplant. advance diagnostic and therapeutic techniques will be provided for comprehensive treatment and exceptional care.
Speaking on the occasion, Dr. Sushmita Roychowdhury, Director of Pulmonology, Fortis Hospital Anandpur says, “The clinic aims to take a comprehensive and multidisciplinary approach for patients with end-stage lung and cardiac conditions. The clinic will assess these patients, optimize therapy and in those who qualify for lung or heart transplant, list them and prepare the suitable patients for transplant.”
Dr. K. M. Mandana, Director, CTVS / Heart Transplant, Fortis Hospital Anandpur added “The Clinic aims at providing specialized care to patients suffering from cardiological diseases and lung failure, offering innovative treatments and therapies to improve their quality of life. The clinic will also aim to improve patient outcomes by providing early diagnosis and treatment of cardiovascular conditions. The Lung Heart Clinic is a new division offering specialized care for individuals suffering from congestive Lung failure and other heart-lung diseases.”
Mr. Ashish Mukherjee, Facility Director at Fortis Hospital Anandapur, said “The newly launched Lung-Heart Clinic is committed to providing accessible treatment for individuals with heart and pulmonary diseases. The clinic will be led by a team of leading doctors with extensive experience in managing patients with end-stage heart and lung failure. The team will evaluate patients based on their physical condition and co-morbidities, if transplant is a suitable option, they will follow the necessary registration and regulations. Our primary objective is to enhance the health and quality of life of patients with end-stage heart and lung failure, and clinic will play a pivotal role in achieving this goal.”
